Christian Waage
General Counsel
Gossamer Bio, Inc. (GOSS)Board Member
Heron Therapeutics, Inc. (HRTX)Equibles does not estimate personal net worth.
Get an email with a short summary when Gossamer Bio, Inc. publishes a filing, an earnings call transcript or a press release.
Get GOSS alertsAbout Christian Waage
Christian Waage is recorded as General Counsel at Gossamer Bio, Inc. (GOSS) and Board Member at Heron Therapeutics, Inc. (HRTX) since January 1, 2016. The newest filing on record that lists Christian Waage as General Counsel at Gossamer Bio, Inc. (GOSS) is dated April 27, 2021. The newest filing on record that lists Christian Waage as Board Member at Heron Therapeutics, Inc. (HRTX) is dated April 30, 2026. Heron Therapeutics, Inc. reported in an 8-K filed June 18, 2024 that Christian Waage was appointed Director, effective June 13, 2024. The proxy statement of Gossamer Bio, Inc. reports total compensation of $1,650,988 for Christian Waage in fiscal 2021, including a base salary of $411,742. Disclosed compensation is on record for 4 fiscal years. Gossamer Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Heron Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Gossamer Bio, Inc. includes Faheem Hasnain (CEO and Chairman), Bryan Giraudo (CFO and COO), Gregory A. Ciongoli (Board Member) and 7 others.
“to elect six director nominees: Craig Collard, Sharmila Dissanaike, M.D., FACS, FCCM, Craig Johnson, Susan Rodriguez, Christian Waage, and Adam Morgan, to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified”
Affiliation history
-
Current
2016-01-01–present
Last confirmed April 30, 2026
-
Gossamer Bio, Inc. (GOSS)
Proxy statement
CurrentStart not stated–present
Last confirmed April 24, 2026
-
Current
Start not stated–present
Last confirmed April 27, 2021
Company network
Biotechnology · Healthcare
Board Member
2016-01-01–present
Leadership on record at Gossamer Bio, Inc.
- Faheem Hasnain CEO, Chairman
- Bryan Giraudo CFO, COO
- Gregory A. Ciongoli Board Member
- John Quisel Board Member
- John Quisel, J.D., Ph.D. Board Member
- Russell Cox Board Member
- Sandra Milligan Board Member
- Sandra Milligan, M.D., J.D. Board Member
- Skye Drynan Board Member
- Steven Nathan Board Member
Leadership on record at Heron Therapeutics, Inc.
- Craig Collard CEO, Board Member
- Adam Morgan Chairman, Board Member
- Ira Duarte CFO, Chief Accounting Officer
- Mark Hensley COO
- Lisa Peraza Chief Accounting Officer
- Craig Johnson Board Member
- Kevin Kotler Board Member
- Michael Kaseta Board Member
- Sharmila Dissanaike Board Member
- Sharmila Dissanaike, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Gossamer Bio, Inc. (GOSS) | Executive Vice President, Technical Operations and Administration | $411,742 | $1,650,988 |
| 2020 | Gossamer Bio, Inc. (GOSS) | Executive Vice President, Technical Operations and Administration | $399,750 | $1,990,351 |
| 2019 | Gossamer Bio, Inc. (GOSS) | Executive Vice President, Technical Operations and Administration | $387,955 | $2,060,653 |
| 2018 | Gossamer Bio, Inc. (GOSS) | Executive Vice President and General Counsel | $365,794 | $867,304 |